You are here: Industry Insights > AI

News List

AI in Pharmacovigilance: Predicting & Preventing Drug Risks Nurah Ekhlaque
November 19, 2024
Discover how AI in pharmacovigilance improves drug safety by predicting risks, identifying harmful interactions, and enhancing patient outcomes.
Key Considerations for Cold Chain Distribution in Cell Therapy Saher Haider
October 16, 2024
In this article, we focus on the key factors that influence cold chain distribution in cell therapy, including temperature stability, packaging and handling challenges, and compliance with regulatory standards.
Advancing Cryogenic Cold Chain Technology for Cell Therapy Products Saher Haider
October 15, 2024
Unlike conventional temperature-sensitive pharmaceutical products, cell therapy products have the most stringent requirements for cold chain logistics.In this article, we will dive deeper into cryogenic technology used at every step of the cold chain supp
Optimizing Cold Chain Logistics for Cell Therapy Products Saher Haider
August 06, 2024
In this article, we will explore the logistical challenges posed by this immensely sensitive class of Cell therapy products, and how they can be maintained.
iotaSciences Raises Equity Financing Round to Drive Further Business Expansion for Its Automated Single-Cell Biology Handling Technologies Biotech Newswire
August 01, 2024
New funds will support ongoing commercial activities in Europe, the U.S and Asia and further enhance the development of a next-generation single-cell cloning platform.
British Journal of Cancer: Zurletrectinib Is a Next-Generation TRK Inhibitor With Strong Intracranial Activity Against NTRK Fusion-Positive Tumors With On-Target Resistance to First-generation Agents July 31, 2024
Zurletrectinib is a next-generation TRK inhibitor with strong intracranial activity against NTRK fusion-positive tumors with on-target resistance to first-generation agents.
Research Progress on the Pharmacological Effects and Molecular Mechanisms of Baicalein Xiaomichong
July 11, 2024
Baicalein, a flavonoid monomer compound isolated from the dried roots of the traditional Chinese medicinal herb Scutellaria baicalensis, serves as the primary pharmacological material basis of the herb.
Research Progress on the Protective Mechanism of Ligustrazine Against Vascular Endothelial Injury Xiaomichong
July 04, 2024
Tetramethylpyrazine (TMP), also known as Ligustrazine, is one of the main active ingredients of Chuanxiong, an active alkaloid extracted from its rhizomes. TMP has been widely used in China to treat cardiovascular diseases such as hypertension.
Research Progress on Commonly Used Antifungal Drugs and Their Resistance Mechanisms Against Candida Albicans Infections Xiaomichong
June 28, 2024
Candida albicans is the primary cause of candidiasis, an acute, subacute, or chronic infection that poses a severe threat to human health due to its complex and varying clinical symptoms.
Research Progress on the Antifungal Mechanism of Natural Products Against Candida Species (Part 2) Xiaomichong
June 28, 2024
This article will continue to introduce the antifungal mechanism of natural products achieved through influencing the changes in cellular structures such as the cell wall, cell membrane, and mitochondria of Candida species